patent/EA-202092719-A1

Predicate	Object
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-08
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08
filingDate	2019-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate	2021-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	EA-202092719-A1
titleOfInvention	BENZENESULPHONAMIDE COMPOUNDS AND THEIR APPLICATION AS THERAPEUTIC AGENTS
abstract	The present invention relates to benzenesulfonamide compounds in the form of their stereoisomers, enantiomers, tautomers, or mixtures thereof; or to their pharmaceutically acceptable salts, solvates or prodrugs for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy and / or disorders with epileptic seizures.
priorityDate	2018-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421019667 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7370

Total number of triples: 19.